Pharmaceuticals welcome EPA

The January implementation of the European Partnership Agreement (EPA) with the European Union has been welcomed by pharmaceutical exporters with the European markets in their sights. Laura Castellanos, executive director of the Dominican Pharmaceutical Industry Association (INFADOMI) said that logistical issues as well as the high freight and transport costs still pose a problem for the sector. Quoted in Hoy, Castellanos explained that costs have made it more difficult to export to Europe, in comparison to Latin America, but that the possibility for this to change exists, albeit slowly.

Despite the fact that the sector doesn’t currently export anything to the EU, the doors are now wide open for exports to this market, says Castellanos.